| Announce Date | 10/21/2025 |
| EPS Normalized Actual | $4.98 (Beat by $0.34) |
| EPS GAAP Actual | $4.98 (Beat by $0.34) |
| Revenue Actual | $1.04598B |
| Revenue Surprise | Beat by $1045.98M |
| Announce Date | 03/27/2026 (Pre-Market) |
| EPS Normalized Estimate | $4.81 |
| EPS GAAP Estimate | $4.81 |
| Revenue Estimate | $1.014B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 27.96 | 16.96 | 27.59266 | 28.2658 | 1 |
| Dec 2029 | 27.22 | 17.42 | 26.43897 | 27.75681 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.02 | 5.02 | 1.04598B | 2.47% | 1045.98M |
| FQ2 2025 (Jun 2025) | -0.2 | -0.2 | 1.05055B | 1.03% | 1050.55M |
| FQ1 2025 (Mar 2025) | 4.35 | 4.35 | 0.969314B | -0.88% | 969.31M |
| FQ4 2024 (Dec 2024) | 3.88 | 3.88 | 1.03729B | 2.1% | 1037.29M |
| FQ3 2024 (Sep 2024) | 4.13 | 4.13 | 1.02017B | -2.56% | 1020.17M |
| FQ2 2024 (Jun 2024) | 4.94 | 4.94 | 1.03974B | 100% | 1039.74M |
| FQ1 2024 (Mar 2024) | 4.35 | 4.35 | 0.977828B | 100% | 977.83M |
| FQ4 2023 (Dec 2023) | 0.0003 | 0.0003 | 1.01553B | -11.42% | 1015.53M |
FQ4 Announce Date
03/27/2026 (Pre-Market)
Consensus EPS Estimates
4.81
Consensus Revenue Estimates
1.014B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 5.51333 | -- | 5.4517 | 5.57421 | 1 |
| FQ3 2026 (Sep 2026) | 4.7 | -6.81 | 4.68099 | 4.73671 | 2 |
| FQ2 2026 (Jun 2026) | 5.05 | 103.96 | 5.02958 | 5.08944 | 2 |
| FQ1 2026 (Mar 2026) | 4.81 | 9.56 | 4.79055 | 4.84757 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 1.07B | -- | 1.06B | 1.08B | 1 |
| FQ3 2026 (Sep 2026) | 1.09B | 4.3 | 1.09B | 1.1B | 3 |
| FQ2 2026 (Jun 2026) | 1.09B | 3.62 | 1.09B | 1.1B | 3 |
| FQ1 2026 (Mar 2026) | 1.01B | 4.41 | 1.01B | 1.02B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.02 | 5.02 | 100% | |
| FQ2 2025 (Jun 2025) | -0.2 | -0.2 | 100% | |
| FQ1 2025 (Mar 2025) | 4.35 | 4.35 | 100% | |
| FQ4 2024 (Dec 2024) | 3.88 | 3.88 | 100% | |
| FQ3 2024 (Sep 2024) | 4.13 | 4.13 | 100% | |
| FQ2 2024 (Jun 2024) | 4.94 | 4.94 | 100% | |
| FQ1 2024 (Mar 2024) | 4.35 | 4.35 | 100% | |
| FQ4 2023 (Dec 2023) | 0.0003 | 0.0003 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.05B | $1045.98M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.05B | $1050.55M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.97B | $969.31M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.04B | $1037.29M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.02B | $1020.17M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.04B | $1039.74M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.98B | $977.83M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.02B | $1015.53M | 100% |